The nurse's role in misoprostol induction: a proposed protocol.

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Nursing Practice

Background:

• Misoprostol (prostaglandin E1) use for labor induction is studied in the US since 1993.
• Current literature includes studies on this non-FDA-approved indication for misoprostol.
• Nurses require knowledge of prostaglandin physiology and misoprostol management for safe labor induction.

Purpose of the Study:

• To review the efficacy and cost-effectiveness of misoprostol for labor induction.
• To provide nurses with a research-based protocol for managing misoprostol in labor.
• To address the need for standardized protocols in the absence of FDA approval for this indication.

Main Methods:

• Literature review of studies on misoprostol, oxytocin, and prostaglandin E2 for labor induction.
• Analysis of efficacy, cost, and safety data.
• Development of a sample nursing protocol based on research findings.

Main Results:

• Misoprostol demonstrates equal or greater effectiveness in labor induction compared to oxytocin and prostaglandin E2.
• Misoprostol offers a more cost-effective alternative for labor induction.
• Research supports the safety and efficacy of misoprostol for this indication.

Conclusions:

• Misoprostol is a viable, effective, and economical option for labor induction.
• A standardized protocol is essential for nurses to ensure safe mother and fetus outcomes during misoprostol induction.
• Further research and protocol development can support evidence-based nursing practice for misoprostol use.